The Directors of MGC Pharmaceuticals Ltd (the "Company") request that the Company’s securities be placed in a voluntary trading halt immediately in accordance with ASX Listing Rule 17.1, pending the release of an announcement by the Company regarding a material transaction in relation to the award of a full medical cannabis production and cultivation facility contract in the European Union (EU), and a related capital raising.
The Company requests that the trading halt end on the earlier of the commencement of normal trading on Wednesday 11 April 2018, or when the detailed announcement regarding the full details of the transaction is released to the market.
Ann: Trading Halt, page-3
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $3.279K | 8.598K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1707 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 718 | 2 |
View Market Depth
| Last trade - 15.45pm 03/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |